45 results about "Ovotransferrin" patented technology

In some embodiments, the present disclosure relates to an avian-free egg white composition including 45-63% Ovalbumin, 9-15% Ovotransferrin, 0-15% Ovomucoid, 3-5% Ovoglobulin G2, 3-5% Ovoglobulin G3, 2.5-5% Ovomucin, 3-5% Lysozyme, 1-2% Ovoinhibitor, 0.8-1.5% Ovoglycoprotein, 0.6-1.0% Flavoprotein, 0.3-0.8% Ovomacroglobulin, 0.02-0.1% Avidin, and 0.02-0.1% Cystatin. In some embodiments, the composition includes an edible yeast and one or more of the preceding proteins. In some embodiments, the avian-free egg white further includes one or more of: flavor enhancers, calcium supplements, added vitamins, and a gelling agent. In some embodiments, the present disclosure pertains to a non-allergenic egg-white composition for human consumption. In some embodiments, the present disclosure pertains to methods of making the avian-free egg-white composition.

In some embodiments, the present disclosure relates to an avian-free egg white composition comprising 45-63% Ovalbumin, 9-15% Ovotransferrin, 0-15% Ovomucoid, 3-5% Ovoglobulin G2, 3-5% Ovoglobulin G3, 2.5-5% Ovomucin, 3-5% Lysozyme, 1-2% Ovoinhibitor, 0.8-1.5% Ovoglycoprotein, 0.6-1.0% Flavoprotein, 0.3-0.8% Ovomacroglobulin, 0.02-0.1% Avidin, and 0.02-0.1% Cystatin. In some embodiments, the composition comprises an edible yeast and one or more of the preceding proteins. In some embodiments, the avian-free egg white further comprises one or more of: flavor enhancers, calcium supplements, added vitamins, and a gelling agent. In some embodiments, the present disclosure pertains to a non-allergenic egg-white composition for human consumption. In some embodiments, the present disclosure pertains to methods of making the avian-free egg-white composition.

Metallo-proteins including but not limited to lactoferrin (LF), transferrin (TF) and ovotransferrin (OTF) (all members of transferrin family), ceruloplasmin (CP) and metallo-thionein (MT) were found to stabilize and enhance the bio-functional activity of tocotrienol (T3), T3 mixtures or derivates. The synergism between MP and T3 also promote the intestinal transfer and the ultimate bio-availability of T3 and T3-derivatives for physiological functions. Such functional synergism includes hypocholesterolemic, anti-thrombotic, antioxidant, anti-athermogenic, anti-inflammatory and immuno-regulatory activities of T3 agents. These T3 compositions are useful as pharmaceuticals, in cosmetics, in foods and as nutritional supplements.

The present invention pertains to an in vitro method for detecting intestinal barrier failure in animals, the method comprising the following steps: a) collecting intestinal sample material of an individual animal or of an animal population; and b) determining the amount of at least one protein marker contained in said sample material; wherein the at least one protein marker comprises or consists of ovotransferrin or a functional fragment thereof, and wherein an increased amount of said at least one protein marker contained in said sample versus a reference sample indicates intestinal barrier failure.

Metallo-proteins including but not limited to lactoferrin (LF), transferrin (TF) and ovotransferrin (OTF) (all members of transferrin family), ceruloplasmin (CP) and metallo-thionein (MT) were found to stabilize and enhance the bio-functional activity of tocotrienol (T3), T3 mixtures or derivates. The synergism between MP and T3 also promote the intestinal transfer and the ultimate bio-availability of T3 and T3-derivatives for physiological functions. Such functional synergism includes hypocholesterolemic, anti-thrombotic, antioxidant, anti-athermogenic, anti-inflammatory and immuno-regulatory activities of T3 agents. Addition of a non-protein-type metal chelator provided further improvement in the action of the bio-functional activity of T3. These T3 compositions are useful as pharmaceuticals, in cosmetics, in foods and as nutritional supplements.

The invention discloses a method for separating and extracting ovotransferrin, and particularly provides a simple separation and extraction method which has the advantage of high product purity and can implement industrial production. The method comprises the following steps: regulating the pH value of a mucin-free egg white solution to 7.5-9.0, and extracting with an ethanol precipitation method to obtain an ovotransferrin crude product; and purifying the ovotransferrin crude product by a two-step weakly-acidic cation exchange resin chromatography method, and dialyzing the purified ovotransferrin at 1-10 DEG C for desalination, thereby obtaining the high-purity ovotransferrin. The ovotransferrin is extracted and separated by an alcohol precipitation method combined with a weakly-acidic cation exchange method: the ovotransferrin is prepared into a compound under alkaline conditions, and subjected to the alcohol precipitation method to obtain the ovotransferrin crude product; and the ovotransferrin crude product is subjected to the two-step weakly-acidic cation exchange resin chromatography method. The product purity is high; the preparation scale and yield of the ovotransferrin are enhanced; and the method is simple, and is beneficial to implementing industrialized production.

The invention provides fully sterilized heated whole egg liquid with high foamability and a manufacturing method thereof. The heated whole egg liquid of the present invention is a heated whole egg liquid in which Salmonella is negative in every 25 g sample weight and the coliform group is less than 10 / g. When the aforementioned heated whole egg liquid is electrophoresed by the Native-PAGE method, the detection Two ovotransferrin bands comprising the first band and the second band with a faster swimming speed than the first band were obtained, and the aforementioned two ovotransferrin bands were measured with a densitometer For each depth, the measured value of the first band is 50% or more and 200% or less of the measured value of the second band. Thereby, it is possible to provide heated whole egg liquid with high safety and high foamability.